WallStSmart

JBS N.V. (JBS)vsPrenetics Global Ltd (PRE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JBS N.V. generates 73413% more annual revenue ($88.27B vs $120.07M). JBS leads profitability with a 2.0% profit margin vs -42.0%. JBS earns a higher WallStSmart Score of 45/100 (D+).

JBS

Hold

45

out of 100

Grade: D+

Growth: 4.7Profit: 5.5Value: 6.7Quality: 6.0
Piotroski: 6/9Altman Z: 2.62

PRE

Avoid

32

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 7.0
Piotroski: 5/9Altman Z: -0.01

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JBS3 strengths · Avg: 9.0/10
P/E RatioValuation
7.6x10/10

Attractively priced relative to earnings

Return on EquityProfitability
22.5%9/10

Every $100 of equity generates 22 in profit

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

PRE3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
107.7%10/10

Revenue surging 107.7% year-over-year

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

Areas to Watch

JBS4 concerns · Avg: 2.5/10
Profit MarginProfitability
2.0%3/10

2.0% margin — thin

Operating MarginProfitability
2.4%3/10

Operating margin of 2.4%

EPS GrowthGrowth
-57.2%2/10

Earnings declined 57.2%

Free Cash FlowQuality
$-6.99B2/10

Negative free cash flow — burning cash

PRE4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$310.43M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-22.1%2/10

ROE of -22.1% — below average capital efficiency

Free Cash FlowQuality
$-12.33M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : JBS

The strongest argument for JBS centers on P/E Ratio, Return on Equity, Price/Book. Revenue growth of 10.7% demonstrates continued momentum.

Bull Case : PRE

The strongest argument for PRE centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 107.7% demonstrates continued momentum.

Bear Case : JBS

The primary concerns for JBS are Profit Margin, Operating Margin, EPS Growth. Debt-to-equity of 2.81 is elevated, increasing financial risk. Thin 2.0% margins leave little buffer for downturns.

Bear Case : PRE

The primary concerns for PRE are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

JBS profiles as a value stock while PRE is a hypergrowth play — different risk/reward profiles.

PRE is growing revenue faster at 107.7% — sustainability is the question.

PRE generates stronger free cash flow (-12M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

JBS scores higher overall (45/100 vs 32/100) and 10.7% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

JBS N.V.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

JBS N.V., is a protein and food company globally. The company is headquartered in Amstelveen, Netherlands.

Prenetics Global Ltd

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Prenetics Global Ltd (PRE) is an innovative health technology company that specializes in advanced genetic and diagnostic testing solutions, offering invaluable health insights to consumers and healthcare professionals alike. With a robust focus on research and development, Prenetics has built a strong international footprint through strategic partnerships and collaborations, enhancing its market visibility. As a frontrunner in personalized medicine, the company is strategically positioned to leverage the growing demand for accessible health data, presenting a compelling investment opportunity within the dynamic healthcare sector.

Want to dig deeper into these stocks?